235 related articles for article (PubMed ID: 37026479)
21. The role of RNA editing enzyme ADAR1 in human disease.
Song B; Shiromoto Y; Minakuchi M; Nishikura K
Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1665. PubMed ID: 34105255
[TBL] [Abstract][Full Text] [Related]
22. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
[TBL] [Abstract][Full Text] [Related]
23. ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep.
Sinigaglia K; Wiatrek D; Khan A; Michalik D; Sambrani N; Sedmík J; Vukić D; O'Connell MA; Keegan LP
Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):356-369. PubMed ID: 30391332
[TBL] [Abstract][Full Text] [Related]
24. Intracellular localization of differentially regulated RNA-specific adenosine deaminase isoforms in inflammation.
Yang JH; Nie Y; Zhao Q; Su Y; Pypaert M; Su H; Rabinovici R
J Biol Chem; 2003 Nov; 278(46):45833-42. PubMed ID: 12954622
[TBL] [Abstract][Full Text] [Related]
25. Adenosine deaminases acting on RNA, RNA editing, and interferon action.
George CX; Gan Z; Liu Y; Samuel CE
J Interferon Cytokine Res; 2011 Jan; 31(1):99-117. PubMed ID: 21182352
[TBL] [Abstract][Full Text] [Related]
26. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself.
Liddicoat BJ; Piskol R; Chalk AM; Ramaswami G; Higuchi M; Hartner JC; Li JB; Seeburg PH; Walkley CR
Science; 2015 Sep; 349(6252):1115-20. PubMed ID: 26275108
[TBL] [Abstract][Full Text] [Related]
27. An Aicardi-Goutières Syndrome-Causative Point Mutation in
Inoue M; Nakahama T; Yamasaki R; Shibuya T; Kim JI; Todo H; Xing Y; Kato Y; Morii E; Kawahara Y
J Immunol; 2021 Dec; 207(12):3016-3027. PubMed ID: 34772697
[TBL] [Abstract][Full Text] [Related]
28. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
Guo X; Wiley CA; Steinman RA; Sheng Y; Ji B; Wang J; Zhang L; Wang T; Zenatai M; Billiar TR; Wang Q
J Neuroinflammation; 2021 Jul; 18(1):169. PubMed ID: 34332594
[TBL] [Abstract][Full Text] [Related]
29. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation.
de Reuver R; Verdonck S; Dierick E; Nemegeer J; Hessmann E; Ahmad S; Jans M; Blancke G; Van Nieuwerburgh F; Botzki A; Vereecke L; van Loo G; Declercq W; Hur S; Vandenabeele P; Maelfait J
Nature; 2022 Jul; 607(7920):784-789. PubMed ID: 35859175
[TBL] [Abstract][Full Text] [Related]
30. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.
Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM
Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325
[TBL] [Abstract][Full Text] [Related]
31. Identification of ADAR1 p150 and p110 Associated Edit Sites.
Sun T; Rosenberg BR; Chung H; Rice CM
Methods Mol Biol; 2023; 2651():285-294. PubMed ID: 36892775
[TBL] [Abstract][Full Text] [Related]
32. Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous.
Keegan LP; Hajji K; O'Connell MA
Acc Chem Res; 2023 Nov; 56(22):3165-3174. PubMed ID: 37906879
[TBL] [Abstract][Full Text] [Related]
33. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
Liu Y; Wolff KC; Jacobs BL; Samuel CE
Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
[TBL] [Abstract][Full Text] [Related]
34. ADAR1 averts fatal type I interferon induction by ZBP1.
Jiao H; Wachsmuth L; Wolf S; Lohmann J; Nagata M; Kaya GG; Oikonomou N; Kondylis V; Rogg M; Diebold M; Tröder SE; Zevnik B; Prinz M; Schell C; Young GR; Kassiotis G; Pasparakis M
Nature; 2022 Jul; 607(7920):776-783. PubMed ID: 35859176
[TBL] [Abstract][Full Text] [Related]
35. Functional conservation in human and Drosophila of Metazoan ADAR2 involved in RNA editing: loss of ADAR1 in insects.
Keegan LP; McGurk L; Palavicini JP; Brindle J; Paro S; Li X; Rosenthal JJ; O'Connell MA
Nucleic Acids Res; 2011 Sep; 39(16):7249-62. PubMed ID: 21622951
[TBL] [Abstract][Full Text] [Related]
36. ADAR RNA editing in human disease; more to it than meets the I.
Gallo A; Vukic D; Michalík D; O'Connell MA; Keegan LP
Hum Genet; 2017 Sep; 136(9):1265-1278. PubMed ID: 28913566
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of a constitutively expressed Ctenopharyngodon idella ADAR1 splicing isoform (CiADAR1a).
Liu X; Huang K; Hou Q; Sun Z; Wang B; Lin G; Li D; Liu Y; Xu X; Hu C
Dev Comp Immunol; 2016 Oct; 63():10-7. PubMed ID: 27185203
[TBL] [Abstract][Full Text] [Related]
38. Editing of glutamate receptor subunit B pre-mRNA by splice-site variants of interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1.
Liu Y; Samuel CE
J Biol Chem; 1999 Feb; 274(8):5070-7. PubMed ID: 9988754
[TBL] [Abstract][Full Text] [Related]
39. Novel insights into double-stranded RNA-mediated immunopathology.
de Reuver R; Maelfait J
Nat Rev Immunol; 2024 Apr; 24(4):235-249. PubMed ID: 37752355
[TBL] [Abstract][Full Text] [Related]
40. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.
Rice GI; Kasher PR; Forte GM; Mannion NM; Greenwood SM; Szynkiewicz M; Dickerson JE; Bhaskar SS; Zampini M; Briggs TA; Jenkinson EM; Bacino CA; Battini R; Bertini E; Brogan PA; Brueton LA; Carpanelli M; De Laet C; de Lonlay P; del Toro M; Desguerre I; Fazzi E; Garcia-Cazorla A; Heiberg A; Kawaguchi M; Kumar R; Lin JP; Lourenco CM; Male AM; Marques W; Mignot C; Olivieri I; Orcesi S; Prabhakar P; Rasmussen M; Robinson RA; Rozenberg F; Schmidt JL; Steindl K; Tan TY; van der Merwe WG; Vanderver A; Vassallo G; Wakeling EL; Wassmer E; Whittaker E; Livingston JH; Lebon P; Suzuki T; McLaughlin PJ; Keegan LP; O'Connell MA; Lovell SC; Crow YJ
Nat Genet; 2012 Nov; 44(11):1243-8. PubMed ID: 23001123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
